AOBiome

AOBiome

Phase 3
Cambridge, United StatesFounded 2013aobiome.com

AOBiome is a world-leading clinical-stage microbiome company focusing on research and development of therapeutics for inflammatory conditions, central nervous system disorders and other diseases. Our proprietary product candidates harness a strain of class-defining, auto-regulating Ammonia Oxidizing Bacteria, or AOB, a human commensal with well-understood and well-characterized biochemical properties that are critical to human health. We believe that the application of AOB has the potential t...

Market Cap
Private
Pipeline
Patents
Publications

Private Company

Total funding raised: $174.6M

About

AOBiome is a world-leading clinical-stage microbiome company focusing on research and development of therapeutics for inflammatory conditions, central nervous system disorders and other diseases. Our proprietary product candidates harness a strain of class-defining, auto-regulating Ammonia Oxidizing Bacteria, or AOB, a human commensal with well-understood and well-characterized biochemical properties that are critical to human health. We believe that the application of AOB has the potential t...

BiologicsMicrobiome

Funding History

4
Total raised:$174.6M
Series D$88MJul 15, 2021
Series C$50MNov 15, 2019
Series B$30MJun 15, 2017
Series A$6.6MOct 15, 2013